Qube Research & Technologies (QRT)
TDOC icon

Qube Research & Technologies (QRT)’s Teladoc Health TDOC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,100
Closed -$14.7K – 4120
2025
Q4 		$14.7K Buy
+2,100
New +$16.4K ﹤0.01% 3415
2023
Q4 		– Sell
-22,200
Closed -$413K – 4722
2023
Q3 		$413K Buy
+22,200
New +$518K ﹤0.01% 2107

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TDOC Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 63,424 shares — an estimated $552K sold.

Qube Research & Technologies (QRT) first reported a position in TDOC in Q1 2020 and held it in 14 quarters. The position peaked at $30.5M in Q3 2023. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 63,424 Teladoc Health shares in Q3 2025, an estimated $552K.
  • Qube Research & Technologies (QRT) first reported a position in Teladoc Health in Q1 2020 and held it in 14 quarters.
  • Qube Research & Technologies (QRT)'s Teladoc Health position peaked at $30.5M in Q3 2023.
  • 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.